Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 65 for “"Drug Resistant Tuberculosis"”.
-
Drug-resistant tuberculosis in children
The number of children globally who develop drug-resistant tuberculosis is unclear, in part due to diagnostic challenges and limited resistance testing, and in part because recording and reporting is not comprehensive. Large numbers of children, however, are exposed to drug resistant bacilli each …
-
An analysis of multi drug resistant tuberculosis control in Vietnam
Multi-drug resistant tuberculosis is a major global health problem. Viet Nam is 14th among 27 MDR-TB high burden countries with an estimated about 5,100 MDR-TB cases among notified TB cases per year. Management of MDR-TB in Viet Nam is one of the main objectives of the TB control programme. This …
-
Age appropriate treatment of drug-resistant tuberculosis in South Africa
<p>Drug-resistant tuberculosis (DR-TB) is a threat to TB control globally. South Africa has the third highest epidemic of DR-TB – following only Russia and China, two much more populous countries. South Africa has stringent guidelines for treating DR-TB; however, little is known about adherence to …
-
Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance
Background: Rifampicin-resistant tuberculosis (RR-TB) accounts for an expanding proportion of incident global TB cases and is a major barrier to global tuberculosis control. There is a need for more effective, safe, and well-tolerated drugs. Linezolid is a repurposed oxazolidinone antimicrobial …
-
Comparative evaluation of molecular-based detection methods for drug resistant tuberculosis
Tuberculosis (TB) is a globally problematic infectious disease and is currently one of the leading causes of death from any infectious disease worldwide. Mycobacterium tuberculosis (MTB) is notorious for developing resistance to currently available treatment, and according to the World Health …
-
The efficacy and safety of bedaquiline in multi-drug resistant tuberculosis
… approved by the FDA for the treatment of multidrug resistant tuberculosis. Due to its recent nature, there exists little information on the efficacy and safety of the drug. A systematic review and meta-analysis was performed to collect what data exist on bedaquiline and assess its efficacy and …
-
Novel therapeutics in the treatment of drug-resistant tuberculosis: a review
Mycobacterium tuberculosis is the causative agent of Tuberculosis infection (TB). TB is still endemic throughout the World and is a significant cause of morbidity and mortality, killing over 4,000 people every day. Although a number of antibiotics have been available for the treatment of TB since …
-
Cardiovascular Risk among Patients with Drug-Resistant Tuberculosis and HIV in South Africa
… South Africa has the highest incidence of drug resistant-tuberculosis (DR-TB) in sub-Saharan Africa and outcomes are poor. Only 54% of patients successfully complete treatment. The prevalence of HIV co-infection and cardiovascular (CVD) risk factors is also increasing. The purpose of this …
-
Conflicted cure: explorting concepts of default and adherence in drug resistant tuberculosis patients in Khayelitsha
… dissertation examines default and adherence in drug-resistant tuberculosis (DR-TB) patients in Khayelitsha, Cape Town, South Africa. The ethnographic data is drawn from three and a half months of participant-observation, illness-narrative interviews, in-depth interviews, focus groups, …
-
Risk of Aminoglycoside-Induced Hearing Loss among Patients with Drug-Resistant Tuberculosis in South Africa
Problem Statement Individuals treated for multidrug-resistant tuberculosis (MDR-TB) with aminoglycosides (AGs) in resource-limited settings often experience permanent hearing loss, but there is no practical, cost-effective means to identify those at higher risk. This dissertation aimed to estimate …
-
WHOLE-GENOME SEQUENCING AND GENE-BASED DIAGNOSIS IN THE COMPLEX BATTLE AGAINST DRUG-RESISTANT TUBERCULOSIS
… (WGS) and gene-based diagnostics in managing drug-resistant (DR) tuberculosis (TB) and proposed an algorithm for predicting DR-TB from genomic data. Reviewing the national strategies for TB diagnosis and treatment in Singapore, Thailand, and Vietnam, we found that the impact of genetic testing …
-
Field deployable low cost microfluidic system for real-time isothermal detection of drug resistant tuberculosis
Tuberculosis (TB) caused by Mycobacterium tuberculosis is a global health issue that is responsible for more than 1.6 million deaths annually; majority of which occur in developing nations. In addition to routine TB, often inappropriate use of antibacterial drugs results in multi-drug resistant …
-
Extensively drug-resistant tuberculosis in Africa: prevalence and factors associated: a systematic review and meta-analysis
… information regarding prevalence of extensively drugresistant tuberculosis (XDR-TB) in Africa. Although countries in Africa conduct national tuberculosis surveys on a regular basis, this information has not been systematically reviewed to ascertain the overall prevalence of XDR-TB in Africa. …
-
Clinical experiences of health care workers caring for drug resistant Tuberculosis patients at Princess Marina Hospital, Gaborone
Background: Tuberculosis (TB) remains a major global health problem and ranks alongside HIV/AIDS as the top infectious killer worldwide, with 9.6 million new cases and 1.5 million deaths estimated to have occurred in 2014. Drug-resistant TB (DR-TB) threatens the global TB control and is a major …
-
Pre-clinical drug development of 9-aminoacridines for malignant glioma and meropenem prodrugs for drug-resistant tuberculosis
The pre-clinical drug development of investigational molecules with encouraging in vitro efficacy require drug metabolism and pharmacokinetic experiments that ultimately characterize "what the body can do to the drug." In chapter one of this thesis, the absorption, distribution, and metabolic …
-
Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis
Multi-drug resistance is increasingly becoming a challenge to tuberculosis control programmes globally. Treatment of multi-drug resistance tuberculosis (MDR-TB) includes aminoglycoside antibiotics which are known to cause hearing loss. Ototoxicity monitoring services are often provided to patients …
-
Understanding Loss to Follow-up from and Quality of Life during Drug-Resistant Tuberculosis Treatment in Pune, India
The treatment and prevention of multidrug resistant tuberculosis (MDR TB) is a significant public health challenge, particularly in India, which accounts for approximately one quarter of the global burden. First, an overview of MDR TB in India and its public sector treatment is provided, including …
-
Mortality risks in multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: a systematic review and meta-regression analysis
Tuberculosis (TB) remains a leading cause of infectious disease mortality globally, and the emergence ofdrug-resistant strains poses a significant threat to TB control efforts. This study aimed to quantify the relative mortality risks associated with multidrug-resistant TB (MDR-TB) and extensively …
-
The Making of a Global Health Crisis: Extensively Drug-Resistant Tuberculosis and Global Science in Rural South Africa
… political and rhetorical origins of extensively drug-resistant tuberculosis (XDR-TB) and the ability of a technical medical term, in concert with local clinical and government responses, to influence global biomedical action. XDR-TB, a form of tuberculosis that is resistant to most …
-
Cost-Effectiveness Study on the Use of Novel Drug-Resistant Tuberculosis Diagnostics and Tuberculosis Preventive Treatment to End Tuberculosis
Background: Tuberculosis (TB) remains a major global health challenge, particularly in high-burden settings and among people with HIV. Achieving the World Health Organization (WHO) End TB Strategy requires improved detection of drug-resistant TB (DR-TB) and effective scale-up of tuberculosis …
Page 1 of 4